Partnering with you on your path toward zero bloodstream infections
Every IV site presents the potential for infection, dislodgment, skin damage and other complications. These complications can potentially cause patient discomfort and pain, extended hospital stays, additional therapy, and surgical intervention—even increased patient mortality.
Nationwide, the annual cost to treat CLABSI exceeds $2.3 billion₁
1 in 4 who contract a CLABSI will die₂
More than 2 central line dressing disruptions can result in a 10x increase in infection risk₃
Evidence has demonstrated an increase in hospital resources, and associated costs, required to treat morbidities due to CRBSIs₄₋₇
Every IV site presents the potential for IV site complications. That is why we provide support and education for both central and peripheral lines, as well as for every brand of catheter.
Most bloodstream infections (BSIs) happen after insertion.⁸ 3M understands that IV care cannot be an afterthought to insertion; it must be an area of passionate focus. This is why we have been collaborating with clinicians for over 35 years to find new ways to continue improving IV care practices.
We provide a robust portfolio of tools and processes, along with the support of 3M Clinical Specialists and Sales Representatives to work hand-in-hand with you each step of the way.
The PEAK Assessment Tool empowers you to drive compliance by streamlining the auditing process and receiving customized, real-time feedback. We understand every journey toward zero is unique, which is why the PEAK Assessment Tool allows you to choose audit scope, audit frequency, data collection method, and how to define success.
For more information, please contact your 3M representative.
Your form was submitted successfully!
An error has occurred while submitting. Please try again later...
1. Provonost P, Needham D, Berenholtz S, et al. An intervention to decrease cather-related bloodstream infections in the ICU. N Engl J Med. 2006; 355(26); 2725.
2. Centers for Disease Control and Prevention. Division of Healthcare Quality Promotion. Making health care safer: reducing bloodstream infections. 2011. https://www.cdc.gov/vitalsigns/pdf/2011-03-vitalsigns.pdf (PDF, 2.75 MB).
3. Timsit, J et al (2012). Dressing disruption is a major risk factor for catheter-related infections. Critical Care Medicine. Vol 40(6) 1707-1714.
4. O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II. Guidelines for the prevention of intravascular catheter–related infections. Clinical infectious diseases. 2002 Dec 1;35(11):1281-307.
5. Blot SI, Depuydt P, Annemans L, Benoit D, Hoste E, De Waele JJ, Decruyenaere J, Vogelaers D, Colardyn F, Vandewoude KH. Clinicaland economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clinical Infectious Diseases. 2005 Dec 1;41(11):1591-8.
6. Renaud B, Brun-Buisson C. Outcomes of primary and catheter-related bacteremia: a cohort and case-control study in critically illpatients. Am J Respir Crit Care Med 2001; 163:1584–90.
7. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg. 2001; 136: 229–234.
8. “Guide to Preventing Central Line-Associated Bloodstream Infections.” Association for Professionals in Infection Control and Epidemiology. 2015.
https://apic.org/Resource_/TinyMceFileManager/2015/APIC_CLABSI_WEB.pdf (PDF, 2.19 MB)